Evidence map›Paper›PMID 31572180›Full record

ArticleFrontiers in pharmacology2019

Acute Liver Failure in a Patient Treated With Metamizole.

Philipp Krisai, Deborah Rudin, David Grünig, Kathrin Scherer, Werner Pichler, Luigi Terracciano, Stephan Krähenbühl

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Liver injury associated with the analgetic drug metamizole.British journal of clinical pharmacology · 2020
    Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Philipp KrisaiCardiovascular Research Institute Basel, University Hospital Basel, Basel, Switzerland.
Deborah RudinDivision of Clinical Pharmacology & Toxicology, University Hospital Basel, Basel, Switzerland.
David GrünigDivision of Clinical Pharmacology & Toxicology, University Hospital Basel, Basel, Switzerland.
Kathrin SchererAllergy Unit, Department of Dermatology, University Hospital Basel, Basel, Switzerland.
Werner PichlerADR-AC GmbH, Berne, Switzerland.
Luigi TerraccianoInstitute of Pathology, University Hospital Basel, Basel, Switzerland.
Stephan KrähenbühlDivision of Clinical Pharmacology & Toxicology, University Hospital Basel, Basel, Switzerland.
University Hospital of Basel · CHADR-AC (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report on a patient who developed acute liver failure while being treated with metamizole. After liver transplantation, the patient recovered rapidly. Liver biopsy showed massive necrosis and lobular infiltration of lymphocytes. A lymphocyte transformation test performed 20 months after transplantation was positive for metamizole.

Indexed as

4-aminoantipyrine (AA)liver failurelymphocyte transformation test (LTT)metamizoleN-methyl-4-aminoantipyrine (MAA)

Identifiers

PMID31572180
PMCPMC6749849
OpenAlexW2964615267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.